Manuel Delgado

580 total citations
19 papers, 269 citations indexed

About

Manuel Delgado is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Manuel Delgado has authored 19 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Manuel Delgado's work include Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Manuel Delgado is often cited by papers focused on Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Manuel Delgado collaborates with scholars based in Spain, Chile and United States. Manuel Delgado's co-authors include J.M. Borró, Diego González, M. de la Torre, A. Pastor, Amparó Solé, L. Guertin, Gustavo Stringel, J D Cook, J.F. Castroagudı́n and Álvaro Mena and has published in prestigious journals such as PLoS ONE, Hepatology and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Manuel Delgado

19 papers receiving 265 citations

Peers

Manuel Delgado

EPIDE

HEPAT

SURGE

ONCOL

Benjamin Rivière France

Mohamad Mouchli United States

Masakuni Tateyama Japan

Vincent Jouannaud France

U Plengvanit Thailand

Jun Pyo Chung South Korea

Xiaoli Zhu China

Makiko Koyabu Japan

Valentina Monti Italy

Manish Manrai India

Benjamin Rivière France

Manuel Delgado

112 ×0.8

EPIDE

119 ×1.1

HEPAT

104 ×1.4

SURGE

19 ×0.3

73 ×1.9

ONCOL

Citations per year, relative to Manuel Delgado Manuel Delgado (= 1×) peers Benjamin Rivière

Countries citing papers authored by Manuel Delgado

Since Specialization

Citations

This map shows the geographic impact of Manuel Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Delgado more than expected).

Fields of papers citing papers by Manuel Delgado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Delgado. The network helps show where Manuel Delgado may publish in the future.

Co-authorship network of co-authors of Manuel Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Delgado. A scholar is included among the top collaborators of Manuel Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Delgado. Manuel Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Turnés, Juan, Diego Rincón, José Luís Calleja, et al.. (2021). Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study. Gastroenterología y Hepatología. 45(5). 342–349. 1 indexed citations

Margusino‐Framiñán, Luis, et al.. (2019). PIN3 SOFOSBUVIR/VELPATASVIR VS GLECAPREVIR/PIBRENTASVIR IN GENOTYPE 3 HEPATITIS C VIRUS INFECTED PATIENTS. Value in Health. 22. S640–S640. 1 indexed citations

Mena, Álvaro, et al.. (2019). Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals. PLoS ONE. 14(6). e0217052–e0217052. 4 indexed citations

Pernas, Berta, Ana Mariño, Álvaro Mena, et al.. (2018). Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies. Journal of Medical Virology. 90(6). 1094–1098. 5 indexed citations

Morano, Luís, Ángeles Castro, Marta Suárez, et al.. (2017). Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients. Journal of Clinical Virology. 88. 58–61. 22 indexed citations

Rimola, Jordi, Álvaro Díaz‐González, Anna Darnell, et al.. (2017). Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events. Hepatology. 67(2). 612–622. 55 indexed citations

Pernas, Berta, Ángeles Castro‐Iglesias, Álvaro Mena, et al.. (2017). Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration. European Journal of Gastroenterology & Hepatology. 29(7). 781–785. 3 indexed citations

Rego‐Pérez, Ignacio, Berta Pernas, Sónia Pértega-Díaz, et al.. (2016). Brief Report: European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression Among HCV and HIV/HCV-Coinfected Patients From Northwest Spain. JAIDS Journal of Acquired Immune Deficiency Syndromes. 73(2). 149–153. 1 indexed citations

Mena, Álvaro, Ángeles Castro‐Iglesias, Manuel Delgado, et al.. (2014). Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing. PLoS ONE. 9(12). e113062–e113062. 9 indexed citations

10.

Calleja, José Luís, J.M. Pascasio, Belén Ruíz‐Antorán, et al.. (2014). Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis. Liver International. 35(1). 90–100. 15 indexed citations

11.

Bartolucci, Jorge, Fernando Verdugo, Ricardo Larrea, et al.. (2014). Estado actual de la terapia con células madre en el tratamiento de las cardiopatías: An update. Revista médica de Chile. 142(8). 1034–1046. 2 indexed citations

12.

Carrión, Flavio, Rubén Lamich, Ema Abarzúa, et al.. (2013). EL TRASPLANTE INTRACORONARIO DE CÉLULAS MONONUCLEARES DE MÉDULA ÓSEA SE ASOCIA A MEJORÍAA LA FUNCIÓN VENTRICULAR IZQUIERDA, EN PACIENTES CON CARDIOPATÍAA DILATADA DE DIFERENTE ETIOLOGÍA: PROYECTO INNOVA CHILE N° 205-4350. Revista chilena de cardiología. 32(1). 11–20. 2 indexed citations

13.

Reig, María, Ana Matilla, Javier Bustamante, et al.. (2010). Recomendaciones de manejo de Sorafenib en pacientes con carcinoma hepatocelular. Gastroenterología y Hepatología. 33(10). 741–752. 9 indexed citations

14.

Torre, Mario, J.M. Borró, Ramiro Fernandez, et al.. (2009). Results of “Twinning Procedure” in Lung Transplantation: Experience in a Single Center. Transplantation Proceedings. 41(6). 2213–2215. 1 indexed citations

15.

Borró, J.M., Amparó Solé, M. de la Torre, et al.. (2008). Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation. Transplantation Proceedings. 40(9). 3090–3093. 69 indexed citations

16.

Delgado, Manuel, Ramiro Fernandez, Marina Paradela, et al.. (2008). Development of Neoplasms During Lung Transplantation Follow-up. Transplantation Proceedings. 40(9). 3094–3096. 16 indexed citations

17.

Castroagudı́n, J.F., Esther Molina, Ihab Abdulkader, et al.. (2007). Sonographic Features of Liver Involvement by Lymphoma. Journal of Ultrasound in Medicine. 26(6). 791–796. 11 indexed citations

18.

Banzo, J., E. Prats, Manuel Delgado, et al.. (2001). [The scintigraphy of somatostatin receptors in the carcinoid tumor].. PubMed. 20(1). 11–8. 6 indexed citations

19.

Stringel, Gustavo, et al.. (1989). Gastrostomy and nissen fundoplication in neurologically impaired children. Journal of Pediatric Surgery. 24(10). 1044–1048. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact